Abstract:Heterogeneous treatment effects (HTEs) are increasingly estimated using machine learning models that produce highly personalized predictions of treatment effects. In practice, however, predicted treatment effects are rarely interpreted, reported, or audited at the individual level but, instead, are often aggregated to broader subgroups, such as demographic segments, risk strata, or markets. We show that such aggregation can induce systematic bias of the group-level causal effect: even when models for predicting the individual-level conditional average treatment effect (CATE) are correctly specified and trained on data from randomized experiments, aggregating the predicted CATEs up to the group level does not, in general, recover the corresponding group average treatment effect (GATE). We develop a unified statistical framework to detect and mitigate this form of group bias in randomized experiments. We first define group bias as the discrepancy between the model-implied and experimentally identified GATEs, derive an asymptotically normal estimator, and then provide a simple-to-implement statistical test. For mitigation, we propose a shrinkage-based bias-correction, and show that the theoretically optimal and empirically feasible solutions have closed-form expressions. The framework is fully general, imposes minimal assumptions, and only requires computing sample moments. We analyze the economic implications of mitigating detected group bias for profit-maximizing personalized targeting, thereby characterizing when bias correction alters targeting decisions and profits, and the trade-offs involved. Applications to large-scale experimental data at major digital platforms validate our theoretical results and demonstrate empirical performance.
Abstract:Algorithms are increasingly used to automate or aid human decisions, yet recent research shows that these algorithms may exhibit bias across legally protected demographic groups. However, data on these groups may be unavailable to organizations or external auditors due to privacy legislation. This paper studies bias detection using an unsupervised clustering tool when data on demographic groups are unavailable. We collaborate with the Dutch Executive Agency for Education to audit an algorithm that was used to assign risk scores to college students at the national level in the Netherlands between 2012-2023. Our audit covers more than 250,000 students from the whole country. The unsupervised clustering tool highlights known disparities between students with a non-European migration background and Dutch origin. Our contributions are three-fold: (1) we assess bias in a real-world, large-scale and high-stakes decision-making process by a governmental organization; (2) we use simulation studies to highlight potential pitfalls of using the unsupervised clustering tool to detect true bias when demographic group data are unavailable and provide recommendations for valid inferences; (3) we provide the unsupervised clustering tool in an open-source library. Our work serves as a starting point for a deliberative assessment by human experts to evaluate potential discrimination in algorithmic-supported decision-making processes.




Abstract:Large language models (LLMs) present an enormous evolution in the strategic potential of conversational recommender systems (CRS). Yet to date, research has predominantly focused upon technical frameworks to implement LLM-driven CRS, rather than end-user evaluations or strategic implications for firms, particularly from the perspective of a small to medium enterprises (SME) that makeup the bedrock of the global economy. In the current paper, we detail the design of an LLM-driven CRS in an SME setting, and its subsequent performance in the field using both objective system metrics and subjective user evaluations. While doing so, we additionally outline a short-form revised ResQue model for evaluating LLM-driven CRS, enabling replicability in a rapidly evolving field. Our results reveal good system performance from a user experience perspective (85.5% recommendation accuracy) but underscore latency, cost, and quality issues challenging business viability. Notably, with a median cost of $0.04 per interaction and a latency of 5.7s, cost-effectiveness and response time emerge as crucial areas for achieving a more user-friendly and economically viable LLM-driven CRS for SME settings. One major driver of these costs is the use of an advanced LLM as a ranker within the retrieval-augmented generation (RAG) technique. Our results additionally indicate that relying solely on approaches such as Prompt-based learning with ChatGPT as the underlying LLM makes it challenging to achieve satisfying quality in a production environment. Strategic considerations for SMEs deploying an LLM-driven CRS are outlined, particularly considering trade-offs in the current technical landscape.




Abstract:Dynamic treatment regimes (DTRs) are used in medicine to tailor sequential treatment decisions to patients by considering patient heterogeneity. Common methods for learning optimal DTRs, however, have shortcomings: they are typically based on outcome prediction and not treatment effect estimation, or they use linear models that are restrictive for patient data from modern electronic health records. To address these shortcomings, we develop two novel methods for learning optimal DTRs that effectively handle complex patient data. We call our methods DTR-CT and DTR-CF. Our methods are based on a data-driven estimation of heterogeneous treatment effects using causal tree methods, specifically causal trees and causal forests, that learn non-linear relationships, control for time-varying confounding, are doubly robust, and explainable. To the best of our knowledge, our paper is the first that adapts causal tree methods for learning optimal DTRs. We evaluate our proposed methods using synthetic data and then apply them to real-world data from intensive care units. Our methods outperform state-of-the-art baselines in terms of cumulative regret and percentage of optimal decisions by a considerable margin. Our work improves treatment recommendations from electronic health record and is thus of direct relevance for personalized medicine.